Charlton Morris Looking for Chief Financial Officer at Houston, TX Full Time

**Chief Financial Officer – Oncology**

The CFO for this innovative oncology cell vaccine start-up will play a pivotal role in directing financial and accounting functions.

This includes overseeing the formulation of annual budgets, engaging in long-term fiscal planning, and actively contributing to commercialisation strategies. The CFO will be crucial in developing pricing strategies, conducting competitive market analyses, and spearheading future financing initiatives, such as leading the Series A funding round in 2024.

Responsibilities

1. Provide direct oversight of all finance and operational activities, ensuring financial integrity and transparency.
2. Manage the annual budgeting process, offering strategic recommendations to the CEO and executive management.
3. Present comprehensive monthly financial statements, encompassing Profit and Loss (P&L), Balance Sheet, and Cash Flow.
4. Spearhead efforts for fundraising initiatives, including Series A financing, and engage in partnering discussions.
5. Establish and cultivate a robust network of potential investors and strategic partners.
6. Lead the creation and delivery of persuasive financial presentations to secure successful fundraising and partnerships.
7. Direct commercialization planning, including the development of pricing models for approved therapies.
8. Collaborate with scientific and regulatory leads to conduct a thorough market landscape analysis, identifying competitive positioning and defining market advantages.

Qualifications

1. A seasoned leader with a minimum of 10 years in a senior financial managerial role within the life sciences or biotechnology sector.
2. Proven track record in fundraising for public or private life science companies, with cumulative funds raised exceeding $100 million, including leading Series A financing rounds.
3. Previous success in exits and/or partnering initiatives.
4. Demonstrated ability to actively contribute to financial efforts in a dynamic start-up environment.
5. Master’s degree or CPA preferred.

Key words:

Biotech, Finance, Series A, fundraise, oncology, cell therapy, immuno oncology, private funding